CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)	12 Months Ended		188 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012
Net Loss	$ (20,263)	$ (11,825)	$ (233,671)
Contributions to capital - expenses paid by shareholders	5,290	13,534	18,924
Issuance of common stock for expenses			8,700
Depreciation and amortization	340	340	29,330
Change in inventory	1,286	536	(1,168)
Change in accounts payable and accrued expenses	12,481	(10,430)	30,134
Net Cash Flows (Used in) Operations	(866)	(7,845)	(147,751)
Purchase of patent			(28,650)
Purchase of Equipment-Production Mold			(1,700)
Purchase office equipment			(2,096)
Net Cash Flows (Used in) Investing Activities			(32,446)
Notes Payable from related party	2,100	8,655	45,218
Payments to related party	(787)	(810)	(11,286)
Proceeds from issuance of common stock			146,712
Net Cash Flows provided by Financing Activities	1,313	7,845	180,644
Net Change in Cash	447		447
Cash at Beginning of Period
Cash at End of Period	447		447
Issuance of 922,900 common shares for a patent- 2000			$ 11,963